Analgesia

CRI Lifetree is recognized as an industry leader in clinical research for acute and chronic pain conditions. All three CRI Lifetree locations have relevant expertise in analgesia clinical trials.

We have conducted in-patient, outpatient, single-dose, multi-dose, dose-ranging and multi-day Phase I-IV trials for several of the major classes of analgesics- opioid, non-opioid, new delivery formulations of existing agents and implanted devices for the treatment of chronic pain.

Our analgesia studies consistently achieve superior enrollment performance and low query rates, delivering reliable data that demonstrate high assay sensitivity.

CRI Lifetree investigators have presented and published a number of important articles, publications and papers and are sought after to lecture internationally. View Abstracts.

Acute and Chronic Pain Expertise